Clinical Trial Update: Trial of XP (Capecitabine/CDDP) Simvastatin in Advanced Gastric Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating XP (capecitabine/cisplatin) with simvastatin in advanced gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (Xeloda) (Capecitabine)
• Cisplatin (Platinol) (cisplatin)
• Simvastatin (Zocor) (simvastatin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Gastric Cancer | Phase 3 | Status: COMPLETED